课题基金 / 基金详情

Type II: UCF I-Corps Site - enhancing technology commercialization to develop a world-class innovation ecosystem

Type II: UCF I-Corps Site - enhancing technology commercialization to develop a world-class innovation ecosystem
类型II:UCF I-Corps Site——加强技术商业化,发展世界一流的创新生态系统
批准号:
1735841
负责人:
Thomas O'Neal
金额:
$29.93万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2022-10-31
关键词:

项目摘要

项目成果

Thomas O'Neal的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project extends the University of Central Florida's (UCF) I-Corps Site for an additional three years beyond their initial three-year award. NSF Innovation Corps (I-Corps) Sites are NSF-funded entities established at universities whose purpose is to nurture and support multiple, local teams to transition their technology concepts into the marketplace. Sites provide infrastructure, advice, resources, networking opportunities, training and modest funding to enable groups to transition their work into the marketplace or into becoming I-Corps Team applicants. I-Corps Sites also strengthen innovation locally and regionally and contribute to the National Innovation Network of mentors, researchers, entrepreneurs and investors. There are two types of I-Corps Site proposals. Type I proposals are submitted by institutions that have not had prior funding as an I-Corps Site. These proposals may request $100,000 per year for up to five years. Type II proposals are submitted by institutions that have had prior funding as an I-Corps Site. These proposals may request up to $100,000 per year for up to three years. The intellectual merits of the I-Corps Site renewal project at UCF include the capture and curation of a deep understanding of (1) the processes, methodologies and programs for entrepreneurship education and technology commercialization, (2) Best practices for transitioning research from the bench top into the marketplace, (3) and distributing this knowledge to collaborators, partners, and affiliates throughout the NIN, and (4) development and adaptation of programs for specialty cohorts supporting local clusters and targeted populations. Additional knowledge and understanding will be gained through the collection of longitudinal data following I-Corps participants after they have completed the curriculum. UCF is an active and engaged partner in the Central Florida innovation ecosystem. The broader impacts from this project directly contribute to the broader community understanding of innovation-based economic development and the importance of research and commercialization. This is critically important to a community that is dependent on tourism and hospitality and the associated lower paying jobs in the region. Building on the initial successes of the UCF I-Corps Site program, successful commercialization of research and inventions generated at the leading research institutions and affiliate organizations in the region, this renewal project has the potential to significantly impact the regional economy. Further, with curriculum that effectively serves Hispanic populations, there is the potential to produce major social and economic impact on a national level. Florida has the third largest Hispanic population in the U.S., with nearly 25% of UCF student population and 34% of Florida business owners being of Hispanic origin, making this an ideal location to develop, deploy, and refine the curriculum.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1108/et-03-2019-0045
发表时间: 2020
期刊: Education + Training
影响因子: --
作者: [Al Haddad, Serina, O'Neal, Thomas, Batarseh, Issa, Martoncik, Amber]
通讯作者: Martoncik, Amber
I-Corps: Multifunctional Additives with Controlled Release Agents
University of Central Florida I-Corps Sites: Enhancing Technology Commercialization to Develop a World-Class Innovation Ecosystem
国内基金
海外基金
基于生境成像与深度学习联合临床特征构建II型卵巢癌术前淋巴结转移预测模型的研究
鸡软骨非变性II型胶原高效制备和靶向递送的关键技术开发与应用示范
青蒿琥酯协同TROP2/线粒体级联靶向的NIR-II多模态诊疗用于晚期TNBC精准诊断与治疗的机制研究
  • 批准号:
    2026JJ30126
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    杨沙
  • 依托单位:
苏合颗粒治疗慢性萎缩性胃炎的临床(II期)评价关键技术研究